We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

    Background

    Nearly one-third of patients with prostate cancer (PCa) experience biochemical recurrence (BCR) after primary definitive treatment. BCR...

    Neal D. Shore, Judd W. Moul, ... Stephen J. Freedland in Prostate Cancer and Prostatic Diseases
    Article Open access 07 September 2023
  2. Neoadjuvant Chemoradiation for Rectal Cancer Achieves Satisfactory Tumour Regression and Local Recurrence – Result of a Dedicated Multi-disciplinary Approach from a South Asian Centre

    Background

    Pre-operative long-course chemoradiotherapy (CRT) for rectal cancer has resulted in improvement in rates of restorative rectal resection...

    Raeed Deen, Dileepa S Ediriweera, ... Pramodh C. Chandrasinghe in BMC Cancer
    Article Open access 04 May 2023
  3. Predicting 5-year recurrence risk in colorectal cancer: development and validation of a histology-based deep learning approach

    Background

    Accurate estimation of the long-term risk of recurrence in patients with non-metastatic colorectal cancer (CRC) is crucial for clinical...

    Han **ao, Zongpeng Weng, ... Sui Peng in British Journal of Cancer
    Article 20 January 2024
  4. Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor

    Background

    Non-muscle invasive bladder cancer can be controlled by transurethral resection of bladder (TURB), but suffers from frequent recurrences in...

    Seung-hwan Jeong, Jang Hee Han, ... Ja Hyeon Ku in BMC Cancer
    Article Open access 08 June 2022
  5. Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma

    Background

    Urothelial carcinoma (UC) is the second most common urological malignancy. Despite numerous molecular markers have been evaluated during...

    Zhicong Yang, Qing Chen, ... Chuanliang Xu in Journal of Translational Medicine
    Article Open access 02 July 2024
  6. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer

    Locoregional recurrences represent a frequently unexpected problem in head and neck squamous cell carcinoma (HNSCC). Relapse often (10–30%) occurs in...

    Federica Ganci, Matteo Allegretti, ... Giovanni Blandino in Biomarker Research
    Article Open access 05 March 2024
  7. Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour

    Background

    Current risk models in solitary fibrous tumour (SFT) were developed using cohorts with short follow-up and cannot reliably identify...

    Tatiana Georgiesh, Ninna Aggerholm-Pedersen, ... Kjetil Boye in British Journal of Cancer
    Article 27 August 2022
  8. Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer

    Background

    This study aimed to develop a novel six-gene expression biomarker panel to enhance the early detection and risk stratification of...

    **’an Ding, Haotian Wu, ... Qun Zhao in Journal of Experimental & Clinical Cancer Research
    Article Open access 28 June 2024
  9. Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis

    Objective

    To compare recurrence and survival in patients with stage III endometrial cancer after radical surgery, followed by either adjuvant...

    Si-yu Cao, Yu Fan, ... **-ke Li in BMC Cancer
    Article Open access 09 January 2023
  10. The Drainage Dysfunction of Meningeal Lymphatic Vessels Is Correlated with the Recurrence of Chronic Subdural Hematoma: a Prospective Study

    Meningeal lymphatic vessels (mLVs) were recently discovered to be involved in the waste drainage process in the brain, which has also been associated...

    Jiahao Zhang, Lei Yu, ... Sheng Chen in Translational Stroke Research
    Article 22 December 2023
  11. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer

    Background

    Gastric cancer (GC) patients who experience recurrence within the first year following surgery (early recurrence [ER]) exhibit worse...

    Keisuke Okuno, Shuichi Watanabe, ... Ajay Goel in British Journal of Cancer
    Article 11 January 2023
  12. Antidepressant medication use and prostate cancer recurrence in men with depressive disorders

    Purpose

    Whether treating prostate cancer survivors with a depressive disorder with antidepressants can affect their cancer outcomes is unknown. We...

    Reina Haque, Stephanie Reading, ... Jeff Slezak in Cancer Causes & Control
    Article Open access 09 September 2022
  13. Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer

    Background

    Lateral neck is not recommended for dissection in patients with pN1a papillary thyroid cancer (PTC), but its recurrence risk has not been...

    Siyuan Xu, Hui Huang, ... Jie Liu in BMC Cancer
    Article Open access 01 December 2022
  14. Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer

    Background

    Circulating tumor DNA (ctDNA) detection following curative-intent surgery could directly reflect the presence of minimal residual disease,...

    Zhaoya Gao, Dandan Huang, ... ** Gu in Journal of Translational Medicine
    Article Open access 30 January 2023
  15. Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort

    Background

    Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in...

    Charlotte Le Cornet, Audrey Y. Jung, ... Renée T. Fortner in Breast Cancer Research
    Article Open access 17 April 2023
  16. Breast Cancer Recurrence and Survival

    Recurrence of breast cancer is a major cause of the disease-specific death. In general, it occurs within 5 years or even up to 10–20 years after...
    Chapter 2021
  17. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis

    Background

    The role of adjuvant transcatheter arterial chemoembolization (TACE) following repeated resection/ablation for recurrent hepatocellular...

    Kaiquan Huang, Tao Qian, ... Tingbo Liang in BMC Cancer
    Article Open access 22 May 2024
  18. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia

    Background

    Oral epithelial dysplasia (OED) is the precursor to oral squamous cell carcinoma which is amongst the top ten cancers worldwide. Prognostic...

    Hanya Mahmood, Adam Shephard, ... Syed Ali Khurram in British Journal of Cancer
    Article Open access 27 September 2023
  19. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis

    Background

    Colorectal cancer (CRC) is the 3rd most common malignancy with the liver being the most common site of metastases. The recurrence rate of...

    Yuan Tian, Yaoqun Wang, ... Geng Liu in BMC Cancer
    Article Open access 08 April 2024
  20. Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

    Background

    The main challenge in follow-up duration of patients with brain metastases after stereotactic radiotherapy is to distinguish between...

    Siran Yang, Yuchao Ma, ... Hongmei Zhang in Radiation Oncology
    Article Open access 14 February 2023
Did you find what you were looking for? Share feedback.